Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
28%
OVERLAP
BY WEIGHT
7
# OF OVERLAPPING
HOLDINGS
FTXH
50
HOLDINGS
14%
ALSO IN THNR
THNR
19
HOLDINGS
39%
ALSO IN FTXH
SECTOR DRIFT (FTXH minus THNR)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in FTXH |
Weight in THNR |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 7.4% | 8.9% | 7.4% |
|
MERCK & CO. INC. | 7.2% | 5.1% | 5.1% |
|
ABBVIE INC | 7.1% | 5.0% | 5.0% |
|
AMGEN INC | 3.5% | 5.4% | 3.5% |
|
REGENERON PHARMACEUTICALS | 3.4% | 6.1% | 3.4% |
FTXH Overweight Relative to THNR
|
JOHNSON & JOHNSON | 6.9% |
|
BRISTOL-MYERS SQUIBB CO | 6.7% |
|
BIOGEN IDEC INC | 3.6% |
|
VIATRIS, INC. | 3.6% |
|
CARDINAL HEALTH INC | 3.4% |
|
VERTEX PHARMACEUTICALS INC | 3.4% |
|
GILEAD SCIENCES INC | 3.1% |
|
INCYTE CORP | 2.4% |
 |
JAZZ PHARMACEUTICALS PLC | 2.4% |
|
UNITED THERAPEUTICS CORP | 2.4% |
FTXH Underweight Relative to THNR
 |
NOVO-NORDISK A/S-SPONS ADR | -9.1% |
 |
INNOVENT BIOLOGICS, INC. | -5.8% |
 |
CHINA PHARMACEUTICAL GROUP | -5.4% |
|
SCHOLAR ROCK HOLDING CORP. | -5.3% |
|
ARROWHEAD PHARMACEUTICALS, INC. | -4.6% |
|
VIKING THERAPEUTICS, INC. | -4.5% |
|
HIMS & HERS HEALTH, INC. CLASS A | -4.4% |
 |
CHUGAI PHARMACEUTICAL CO LTD | -4.2% |
 |
ASTRAZENECA PLC | -3.9% |
|
ZEALAND PHARMA A/S | -3.8% |